A new antiretroviral combination pill that is taken only once a week appears to work as well as daily pills at treating HIV. This is according to interim study findings to be presented next week at the AIDS 2026 conference in Rio de Janeiro, Brazil.
A high-profile court case has thrust the legalities of compounding medicines in South Africa into the spotlight. Behind the immediate legal issues, hide a series of unresolved questions about how we should ensure that compounded medicines used in South Africa are safe, argue Professor Renier Coetzee and Lara van Niekerk.
An NGO offers safe, private HIV services to Men who Have Sex with Men and transgender people in George. Sue Segar met with some of the people using these services, and found the NGO, TB HIV Care are already providing relief from the hostile reactions trans people sometimes experience in government clinics.
Dr Andrew Ross’s idea of sponsoring rural students to study for careers in healthcare has succeeded beyond his dreams. Sue Segar sat down with him and chatted to the four students who bagged the initial fully funded scholarships and who went on to land senior roles in public health.
Being a researcher who studies tuberculosis in the lab is one thing, having the TB bug in your lungs is quite another. Elri Voigt sat down with two of a relatively small number of people who have experienced both.
A survey of 49 000 teenagers in the Western Cape reminds us that preventing violence does not begin in a hospital, a police station or a courtroom. It begins much earlier, in families, schools, sports fields, faith communities and neighbourhoods, writes Western Cape Provincial Minister of Health and Wellness Mireille Wenger.
Eight months after the Supreme Court of Appeal gave the green light for specially trained pharmacists to dispense antiretrovirals without a script from a doctor, the programme remains stuck in the starting blocks. With enabling permits now seemingly on the horizon, Angela Tembo and Dr Deanne Johnston ask if there has been sufficient planning to make the initiative a success.
A court battle over blocked access to Johannesburg clinics has exposed how responsibility for ensuring access to healthcare services is divided between national, provincial and local government. Ahead of local government elections in November, Christina Pitt investigates where exactly the dividing lines lie.
Which vaccines are in use in South Africa and how does our vaccination schedule measure up to international standards? In this #InTheSpotlight special briefing, Catherine Tomlinson unpacks the recent history and details the vaccines currently being used in the country.
There are 12 childhood vaccines in wide use in South Africa. This guide unpacks what you need to know about each of them.
Ten years after its launch in the United States, a new, more effective shingles vaccine is finally set to hit the market in South Africa. While the vaccine, called Shingrix, should soon be available at private sector pharmacies, it seems unlikely that it will be provided in the country’s public healthcare system any time soon.
Provincial debt to the National Health Laboratory Service is not just a financial governance matter, but also a public healthcare service delivery risk that affects diagnoses, treatment, disease surveillance, and government’s ability to protect vulnerable patients, writes Faith Muthambi, chairperson of the Portfolio Committee on Health in the National Assembly.
